New guideline recognises anti-PLA2R as a significant biomarker for membranous nephropathy
In October 2021, the organisation KDIGO (Kidney Disease: Improving Clinical Outcomes) published an updated version of the clinical guideline for the management of patients with glomerulonephritis. This guideline contains recommendations for diagnostics in primary membranous nephropathy, an autoimmune kidney disease…
Read more